KURA

Q: What is the price of Kura Oncology (KURA) today?

The current price of Kura Oncology (KURA) is $ 8.77, representing a 35.13% gain over the past year. The stock began the year trading around $ 10.39 and is currently priced at $ 8.77. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Kura Oncology (KURA) pay dividends?

Kura Oncology (KURA) did not pay dividends over the past year.

Q: Is Kura Oncology (KURA) a good investment?

Kura Oncology (KURA) is currently trading at $ 8.77 with a P/E ratio of -2.92%. This represents a -517% premium compared to its historical average P/E. Over the past year, the stock has gained 35.13 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 35.13%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Kura Oncology Inc.

Price

$ 8.77

return (12m)

35.13%

p/e

-2.92

p/bv

4.68

DIVIDEND YIELD

0.00%

KURA price

KURA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment KURA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

5.16%

3 months

8.00%

1 year

35.13%

2 years

-56.76%

5 years

-67.43%

10 years

0.00%

Fundamentals KURA

review the fundamentals of Kura Oncology shares

P/E

-2.92

Sector: -4.05 Industry: -4.05

P/S (PSR)

12.07

Sector: -3.86 Industry: -3.86

P/BV

4.68

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-37.74%

Sector: -61.23% Industry: -61.23%

ROE

-160.04%

Sector: -60.44% Industry: -60.44%

ROIC

-344.79%

Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

-100.00%

Sector: -39.16% Industry: -39.16%

GROSS MARGIN

99.91%

Sector: 37.91% Industry: 37.91%

OPERATING MARGIN

-100.00%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

-2.95

Sector: -3.92 Industry: -3.92

EV/EBIT

-2.94

Sector: -4.14 Industry: -4.14

PRICE-TO-ASSETS

1.10

Sector: 1.41 Industry: 1.41

BVPS

1.98

Sector: 1.88 Industry: 1.88

EPS

-3.17

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.24

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.76

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

16.39%

Sector: - Industry: -

Fundamentals KURA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.05	6.75	25.92%	2.29%	$ 548.05 B	21.83%
PFE	19.76	1.65	8.35%	6.37%	$ 153.52 B	12.42%
ABBV	83.09	0.00	0.00%	3.35%	$ 351.12 B	6.91%
NVO	11.67	6.01	51.50%	4.53%	$ 182.84 B	33.05%
MRK	15.22	0.00	0.00%	2.97%	$ 277.74 B	28.08%
AZN	28.78	6.04	20.99%	1.69%	$ 294.30 B	17.41%
GILD	19.03	7.16	37.62%	2.45%	$ 161.96 B	28.90%
BMY	16.77	-3.48	-20.72%	4.28%	$ 118.31 B	14.64%
ZTS	19.15	15.37	80.25%	1.74%	$ 51.19 B	28.23%
REGN	17.18	2.48	14.41%	0.48%	$ 77.41 B	31.41%
HALO	24.34	158.01	649.21%	0.00%	$ 7.71 B	22.69%
AMGN	24.08	21.45	89.06%	2.80%	$ 185.71 B	20.98%
MCK	23.47	-1,028.86	-4,383.84%	0.38%	$ 101.86 B	1.09%
VRTX	27.65	5.86	21.18%	0.00%	$ 109.29 B	32.94%
HRMY	11.06	2.02	18.24%	0.00%	$ 1.76 B	18.27%
CAH	28.38	-17.47	-61.56%	1.02%	$ 47.16 B	0.68%
ADMA	18.24	5.61	30.78%	0.00%	$ 2.68 B	28.80%
BIIB	20.96	1.48	7.08%	0.00%	$ 27.10 B	13.07%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

KURA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Kura Oncology

Kura Oncology Inc.

Average Investor10 user rating

4.0 (3 people)

United States

19 years

Founded: 2007

2015

Time since IPO - 11 years

60

Employees

Kura Oncology Inc. (United States) is listed on the Nasdaq and has a market capitalization of $814.88 Millions, with shareholders equity totaling $174.13 Millions.

The company employs approximately 60 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Kura Oncology Inc. reported $67.49 Millions in revenue, generating net income of $-278.67 Millions.

Key financial metrics include a P/E ratio of -2.92, a price-to-book (P/B) ratio of 4.68, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker KURA.

Market cap

$ 814.88 Millions

Net worth

$ 174.13 Millions

$ 174,130,000.00

Assets

$ 738.36 Millions

$ 738,360,000.00

Total Shares Outstanding

88.00 Millions

88,000,000

Average Daily Trading Volume

$ 1.53 Million

$ 1,525,592.40

Sector

Health Care

Industry

Biotechnology

KURA

KURA revenue and profits

Financial Results KURA

DRAG THE FRAME TO SEE MORE DATA

KURA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 814.02 15,48% (12M)

P/E

23.47

0.38%

ROE

-4,383.84%

P/BV

-1,028.86

CAH - Cardinal Health

$ 195.24 32,04% (12M)

P/E

28.38

1.02%

ROE

-61.56%

P/BV

-17.47

JNJ - Johnson & Johnson

$ 227.19 50,46% (12M)

P/E

26.05

2.29%

ROE

25.92%

P/BV

6.75

PFE - Pfizer

$ 26.33 18,59% (12M)

P/E

19.76

6.37%

ROE

8.35%

P/BV

1.65

ABBV - AbbVie

$ 206.60 8,40% (12M)

P/E

83.09

3.35%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 112.16 39,74% (12M)

P/E

15.22

2.97%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 184.74 30,42% (12M)

P/E

28.78

1.69%

ROE

20.99%

P/BV

6.04

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 814.02 15,48% (12 M)

P/L

23.47

0.38%

ROE

-4,383.84%

P/VP

-1,028.86

CAH - Cardinal Health

$ 195.24 32,04% (12 M)

P/L

28.38

1.02%

ROE

-61.56%

P/VP

-17.47

JNJ - Johnson & Johnson

$ 227.19 50,46% (12 M)

P/L

26.05

2.29%

ROE

25.92%

P/VP

6.75

PFE - Pfizer

$ 26.33 18,59% (12 M)

P/L

19.76

6.37%

ROE

8.35%

P/VP

1.65

ABBV - AbbVie

$ 206.60 8,40% (12 M)

P/L

83.09

3.35%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 112.16 39,74% (12 M)

P/L

15.22

2.97%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 184.74 30,42% (12 M)

P/L

28.78

1.69%

ROE

20.99%

P/VP

6.04

Frequently Asked Questions

What is the price of Kura Oncology (KURA) today?

The current price of Kura Oncology (KURA) is $ 8.77, representing a 35.13% gain over the past year. The stock began the year trading around $ 10.39 and is currently priced at $ 8.77. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Kura Oncology (KURA) pay dividends?

Kura Oncology (KURA) did not pay dividends over the past year.

Is Kura Oncology (KURA) a good investment?

Kura Oncology (KURA) is currently trading at $ 8.77 with a P/E ratio of -2.92%. This represents a -517% premium compared to its historical average P/E. Over the past year, the stock has gained 35.13 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 35.13%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kura Oncology (KURA) stock?

You can buy Kura Oncology (KURA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol KURA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Kura Oncology (KURA) yield today?

Over the past month, Kura Oncology (KURA) has returned 5.16% — 35.13% over the past year, and -67.43% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Kura Oncology (KURA) today at the current price of $ 8.77 your total investment would be $ 877.00.

Based on historical performance, the investment would have grown to approximately:

$ 1,185.09 after 1 year
$ 285.64 after 5 years
$ 877.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KURA

Kura Oncology Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KURA

review the fundamentals of Kura Oncology shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Kura Oncology

Kura Oncology Inc.

United States

19 years

2015

60

PROFIT X PRICE KURA

Financial Results KURA

KURA cash flow

Asset, Revenue and Profit Growth - KURA

KURA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions